Search Results - Diagnostics

7 Results

Sort By:

An in vivo QQ-systemic protein delivery technology and applications

BackgroundThis invention contains a new composition of our researchers’ previously patented QQ-protein delivery technology and the in vivo applications of this protein delivery technology via systemic administered proteins for cancer diagnosis and therapy. Many proteins and peptides are used as highly specific and effective therapeutic agents....

Published: 11/9/2021 | Inventor(s): Jianjun Wang, Qianqian Li, Quan Jiang, Feng Jiang, Michael Chopp

Keywords(s): Cancer Therapies, Drug Delivery

Category(s): Diagnostics, Drug Delivery, Life Science, Oncology, Research tools, Therapeutics

Vaginal microbiome snapshot (VMS)

Vaginal Microbiome Sanpshot; a Method for Diagnosing Bacterial Vaginosis and Other Vaginal Disorders WSU Tech#: 13-1141 Technology Summary: Bacterial vaginosis (BV) is a disease of the vagina caused by an imbalance of naturally occurring bacterial flora and is often confused with yeast infection (candidiasis) or infection with Trichomonas vaginalis...

Published: 10/27/2020 | Inventor(s): Robert Akins, Jack Sobel

Keywords(s):

Category(s): Assays, Biomedical, Diagnostic, Diagnostics, Infectious disease

Level of Galectin-3 protein in human blood improves PSA test results

Level of Galectin-3 Protein in Human Blood Improves PSA Test Results WSU Tech#: 13-1133 Technology Summary: For determining prostate cancer aggressiveness, PSA alone is not reliable, as it gives a high number of false positive and false negative results. There are about 25,000 publications on other markers in addition to PSA and as of yet, none...

Published: 3/3/2020 | Inventor(s): Avraham Raz, Vitaly Balan, Elisabeth Heath, Lance Heilbrun

Keywords(s):

Category(s): Medical, Biomedical, Diagnostics, Oncology

Development of a multimolecular and multimodular biomarker panel for the early screening, molecular distinction and clinical follow-up of patients developing preeclampsia/HELLP syndrome and its preparation for preclinical testing

Development of a Multimolecular and Multimodular Biomarker Panel for the Early Screening, Molecular Distinction and Clinical Follow-Up of Patients Developing Preeclampsia/HELLP Syndrome and its Preparation for Preclinical Testing WSU Tech#: 12-1110 Technology Summary: Preeclampsia is a pregnancy complication characterized by high blood pressure and...

Published: 3/3/2020 | Inventor(s): Nandor Than, Adi Tarca, Gabor Juhasz, Adrienna Kekesi, Hamutal Meiri, Zoltan Papp, Roberto Romero

Keywords(s):

Category(s): Medical, Biotechnology, Diagnostic, Diagnostics, Genomics/Genetics, Prenatal, Proteomics

Long non-protein-coding RNA molecules as therapeutics for epilepsy.

Long Non-Coding RNA Molecules as Therapeutics for Epilepsy WSU Tech#: 12-1089 Technology Summary: Long Non-coding RNA (lncRNA) were first described in 2002 from mouse, making this a relatively new technology. lncRNA transcripts far exceed the number of protein coding mRNAs in the mammalian transcriptome, but in lower copy numbers. Inventors...

Published: 10/5/2023 | Inventor(s): Jeffrey Loeb, Leonard Lipovich

Keywords(s):

Category(s): Medical, Bioinformatics, Biomedical, Biotechnology, Diagnostic, Diagnostics, Drug Discovery, Pharmaceuticals, Therapeutics

Translation Regulated (TR)-Mediated Gene Expression: Novel Expression and Reporter Vectors

Background: Often referred to as the crucial "drug discovery tool", cell based technology is one of the most significant sectors of pharmaceutical research and development. Of particular importance has been the development of information-rich cellular assays that determine drug candidate efficacy and safety (target identification, validation...

Published: 4/17/2022 | Inventor(s): Leon Carlock, Maria Cypher

Keywords(s): Animal Model, Anti-cancer, Cancer, Cancer risk, Cancer Therapies, Diagnostics, Imaging, Therapeutics

Category(s): Life Science, Diagnostics, Research tools, Assays, Cell lines, Oncology

DNA Molecule Encoding the B3 Adrenegic Receptor

This technology describes the correct protein sequence of the β3 receptor to aid in the development of adult-onset diabetes drugs. Background & Unmet Need: The β3 receptor is currently being developed as a therapeutic target for human obesity and adult onset diabetes mellitus by several pharmaceutical companies. In order to develop...

Published: 3/2/2022 | Inventor(s): James Granneman, Kristine Lahners, Donald Rao

Keywords(s): Diabetes, Disease, DNA, Drug Target, Obesity, Therapeutics

Category(s): Life Science, Metabolic disorders, Diagnostics, Research tools, Receptors/targets